235 Results

People

  1. Kris
    Kris
  2. Scher
    Scher
  3. Krug
    Krug
  4. Morris
    Morris
  5. Norton
    Norton
  6. Azzoli
    Azzoli
  7. Brennan
    Brennan
  8. Kelly
    Kelly
  9. McCormick
    McCormick
  10. Miller
    Miller

Groups

  1. Department of Medicine (121)
  2. Solid Tumor Oncology Division (77)
  3. Hematologic Malignancies, Division of (47)
  4. Center for Hematologic Malignancies (40)
  5. Survivorship Research (39)
  6. Radiology, Department of (35)
  7. Surgery (34)
  8. GSK Faculty (31)
  9. Body Imaging Service (24)
  10. Sloan Kettering Institute Faculty (24)
  1. "edema"
Formats
  1. Journal Article (224)
  2. Review (5)
  3. Research Letter (3)
  4. Conference Paper (2)
  5. Guidelines (1)
Groups
  1. Department of Medicine (121)
  2. Solid Tumor Oncology Division (77)
  3. Hematologic Malignancies, Division of (47)
  4. Center for Hematologic Malignancies (40)
  5. Survivorship Research (39)
  6. Radiology, Department of (35)

More Groups

People
  1. Mark Kris (10)
  2. Howard Scher (9)
  3. Larry Norton (8)
  4. Lee Krug (8)
  5. Michael Morris (8)
  6. Beryl McCormick (7)

More People

Years
  1. 2025 (5)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (3)
  5. 2021 (3)
  6. 2020 (10)

More Years

Publications
  1. Clinical Cancer Research (13)
  2. Journal of Clinical Oncology (13)
  3. Cancer (12)
  4. International Journal of Radiation Oncology, Biology, Physics (11)
  5. Blood (9)
  6. Journal of the National Comprehensive Cancer Network (8)

More Publications

Publishers
  1. Elsevier Inc. (32)
  2. Springer (24)
  3. Wiley Blackwell (17)
  4. Elsevier Science, Inc. (15)
  5. American Association for Cancer Research (13)
  6. American Society of Clinical Oncology (13)

More Publishers

Results (235)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Consensus recommendations for management and counseling of adverse events associated with lorlatinib: A guide for healthcare practitioners
    Guidelines

    Reed, M.; Rosales, A. L. S.; Chioda, M. D.; Parker, L.; Devgan, G.; Kettle, J.
    Advances in Therapy (2020)

    Fulltext@MSK | Save
  • Bendamustine with dexamethasone in relapsed/ refractory systemic light-chain amyloidosis: Results of a phase II study
    Journal Article

    Lentzsch, S.; Lagos, G. G.; Comenzo, R. L.; Zonder, J. A.; Osman, K.; Pan, S.; Bhutani, D.; Pregja, S.; Sanchorawala, V.; Landau, H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
    Journal Article

    Schroeder, M. A.; Jean Khoury, H.; Jagasia, M.; Ali, H.; Schiller, G. J.; Staser, K.; Choi, J.; Gehrs, L.; Arbushites, M. C.; Yan, Y.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: The ANNOUNCE randomized clinical trial
    Journal Article

    Tap, W. D.; Wagner, A. J.; Schöffski, P.; Martin-Broto, J.; Krarup-Hansen, A.; Ganjoo, K. N.; Yen, C. C.; Abdul Razak, A. R.; Spira, A.; Kawai, A.; more...
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Clinician vs patient reporting of baseline and postbaseline symptoms for adverse event assessment in cancer clinical trials
    Research Letter

    Atkinson, T. M.; Dueck, A. C.; Satele, D. V.; Thanarajasingam, G.; Lafky, J. M.; Sloan, J. A.; Basch, E.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: Integrated analysis of three phase 1-2 trials
    Journal Article

    Doebele, R. C.; Drilon, A.; Paz-Ares, L.; Siena, S.; Shaw, A. T.; Farago, A. F.; Blakely, C. M.; Seto, T.; Cho, B. C.; Tosi, D.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Perihematomal edema after intracerebral hemorrhage in patients with active malignancy
    Journal Article

    Gusdon, A. M.; Nyquist, P. A.; Torres-Lopez, V. M.; Leasure, A. C.; Falcone, G. J.; Sheth, K. N.; Sansing, L. H.; Hanley, D. F.; Malani, R.
    Stroke (2020)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Journal Article

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
    Journal Article

    Yacoub, A.; Mascarenhas, J.; Kosiorek, H.; Prchal, J. T.; Berenzon, D.; Baer, M. R.; Ritchie, E.; Silver, R. T.; Kessler, C.; Winton, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Physical and edema therapy management of amyloidosis in the acute care setting: A case report
    Journal Article

    Boudreau, J.; Lagunilla, J.; Kotkiewicz, J.
    Rehabilitation Oncology (2019)

    Fulltext@MSK | Save